In a significant corporate reshuffle, Japanese pharmaceutical firm Shionogi & Co. has committed an additional $2.13 billion to increase its... Read more
Shionogi boosts ViiV Healthcare investment to 21.7% following Pfizer exit
21/01/2026
Published by vivi
